Login / Signup

Pathological findings directing immunotherapy in renal cell carcinomas.

Fadime Eda Gökalp SatıcıYasemin Yuyucu Karabulut
Published in: Immunotherapy (2024)
Tweetable abstract Immunotherapy options in RCC treatment are increasing day by day. In pursuit of this objective, we have explored the role of pathology throughout the process, from the development to the implementation of immunotherapy in this paper.
Keyphrases
  • healthcare
  • single cell
  • cell therapy
  • high grade
  • stem cells
  • renal cell carcinoma
  • bone marrow
  • replacement therapy